CML-18947-80660
5 vaccinations
5 coded responses
42 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 995 / AK
- Registered
- 2021-02-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-10
Dose 1 — Moderna
-
2021-02-28
Registered in v-safe
-
2021-02-28
Survey response — day 14, dose 1MedDRA: Diarrhoea, Injection site discomfort, Injection site pruritus, Pruritus, Rash erythematous — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Since injection: soreness at site ~5days, then okay. 3/24 (2wks later) itchy at site. Then, 3/25, 3/26, 3/27, 3/28 itchy, red rash area with soreness growing + diarrhea the past 3 days.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-03
-
2021-03-10
Dose 2 — Moderna
-
2021-03-10
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Chills, Fatigue or tirednessAdult check-in
-
2021-03-11
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness · Fatigue or tirednessAdult check-in
-
2021-03-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness · Fatigue or tirednessAdult check-in
- 2021-03-17
- 2021-03-24
- 2021-03-31
- 2021-04-08
- 2021-04-14
- 2021-04-21
- 2021-06-09
- 2021-09-12
-
2021-11-08
Dose 3 — Moderna
- 2022-03-10
-
2022-05-02
Dose 4 — Moderna
- 2022-05-02
-
2022-05-03
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness, Swelling · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-05-04
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain, Redness · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-05-05
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Joint pains, Muscle or body achesAdult check-in
-
2022-05-06
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-05-07
- 2022-05-08
- 2022-05-09
- 2022-05-16
- 2022-05-23
- 2022-05-30
- 2022-06-06
- 2022-06-13
-
2022-08-01
Survey response — 3 months, dose 4MedDRA: SARS-CoV-2 test positive — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Tested positive for COVID; my primary provider put me on Paxlovid for 5 days; Tested negative on July 7 & 8MedDRA releases: 2024-11 · check-in free text available
-
2022-08-01
Report sent to call center — 3 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-08-02
-
2022-10-25
Dose 5 — ModernaCo-administered: Flu:Pneumonia
-
2022-10-31
Survey response — days 1–6 daily, dose 5MedDRA: Injection site erythema, Injection site pain, Injection site pruritus, Injection site rash, Rash, Rash erythematous, Rash pruritic — Feeling: Fair · Site: Redness, ItchingFree text: Red, sore then itchy rash around the injection siteMedDRA releases: 2024-11 · check-in free text available
-
2022-10-31
Survey response — 6 months, dose 4MedDRA: Unevaluable event — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Got the updated Moderna booster 10/25/22 and flu and pneumonia.MedDRA releases: 2024-11 · check-in free text available
- 2022-11-01
- 2022-11-08
- 2022-11-15
- 2022-11-22
- 2022-11-29
- 2022-12-06
- 2023-01-25
-
2023-04-25
Survey response — 6 months, dose 5MedDRA: Influenza like illness, Nasopharyngitis — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-10 | Moderna | |
| 2 | 2021-03-10 | Moderna | |
| 3 | 2021-11-08 | Moderna | No |
| 4 | 2022-05-02 | Moderna | No |
| 5 | 2022-10-25 | Moderna | Flu:Pneumonia |
Call center
1 call center case
1 unsuccessful
Free text
Release 4 — day 14, dose 1
Symptoms: Since injection: soreness at site ~5days, then okay. 3/24 (2wks later) itchy at site. Then, 3/25, 3/26, 3/27, 3/28 itchy, red rash area with soreness growing + diarrhea the past 3 days.
Release 12 — 3 months, dose 4
Symptoms: Tested positive for COVID; my primary provider put me on Paxlovid for 5 days; Tested negative on July 7 & 8
Release 12 — 6 months, dose 4
Symptoms: Got the updated Moderna booster 10/25/22 and flu and pneumonia.
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): Red, sore then itchy rash around the injection site
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Influenza like illness | · | · | ✓ |
| SD | Injection site discomfort | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pruritus | ✓ | ✓ | ✓ |
| SD | Rash erythematous | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Injection site erythema | · | · | ✓ |
| SRO | Injection site pain | · | · | ✓ |
| SRO | Injection site pruritus | · | · | ✓ |
| SRO | Injection site rash | · | · | ✓ |
| SRO | Rash | · | · | ✓ |
| SRO | Rash erythematous | · | · | ✓ |
| SRO | Rash pruritic | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release